Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement C1q-like protein 2 (C1QL2) is a secreted C1q-domain containing protein that functions as a synaptic organizer, predominantly expressed in select neuronal populations within the brain[1][3][6]. It forms trimeric and higher-order oligomeric complexes with unique structural features, including calcium-binding sites, and interacts with receptor proteins such as BAI3 (brain-specific angiogenesis inhibitor 3), a GPCR regulating dendritic morphology and synaptic stability[1][2]. C1QL2 organizes postsynaptic kainate receptor complexes by binding to subunits such as GluK2 and GluK4, directing their synaptic localization and modulating excitatory transmission, particularly at hippocampal mossy fiber to CA3 synapses and Purkinje cell synapses[3][4][6]. Genetic studies implicate C1QL2 in neurodevelopmental and neuropsychiatric disorders, including epilepsy and autism, highlighting its critical role in synapse maturation, neurotransmission, and neural plasticity[3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement C1q-like protein 2 (C1QL2).